buprenorphine and Lymphedema

buprenorphine has been researched along with Lymphedema* in 3 studies

Other Studies

3 other study(ies) available for buprenorphine and Lymphedema

ArticleYear
[Puffy hand syndrome: A little-known diagnosis].
    La Revue de medecine interne, 2020, Volume: 41, Issue:10

    Puffy hand syndrome is a rare complication of intravenous drug addiction. Diagnosis is based on the patient's history and clinical examination.. A woman and two men, aged 42, 39 and 36 years old, are described. All had a history of intravenous drug use of heroin and oral buprenorphine misuse. Puffy hand syndrome appeared during drug addiction (n = 2) or after its withdrawal (n = 1). It was associated with acrocyanosis (n = 1) or injection scars (n = 1). Upper limb ultrasonography showed sequelae of venous (n = 3) or arterial (n = 1) thrombosis. An upper limb lymphoscintigraphy in one patient showed decreased radionuclide uptake of axillary lymph node and subdermal reflux tracer in the forearm. Treatment was based on low-stretch bandages to reduce the volume and then elastic compression sleeve for long-term stabilization.. Puffy hand syndrome seen in intravenous drug addicts is poorly understood. It is a chronic complication despite the cessation of drug use. This syndrome has to become more widely known because its management is mandatory, although symptomatic.

    Topics: Adult; Buprenorphine; Diagnosis, Differential; Female; Hand; Heroin Dependence; Humans; Lymphedema; Male; Opiate Substitution Treatment; Substance Abuse, Intravenous; Syndrome

2020
[<< Puffy hands >> syndrome].
    Presse medicale (Paris, France : 1983), 2009, Volume: 38, Issue:1

    Topics: Adult; Buprenorphine; Cocaine-Related Disorders; Hand; Heroin Dependence; Humans; Lymph Nodes; Lymphatic Vessels; Lymphedema; Male; Opioid-Related Disorders; Radionuclide Imaging; Substance Abuse, Intravenous

2009
Puffy hand syndrome due to drug addiction: a case-control study of the pathogenesis.
    Addiction (Abingdon, England), 2006, Volume: 101, Issue:9

    We studied the pathogenesis of puffy hand syndrome of intravenous drug use. We hypothesized that injections of high-dose sublingual buprenorphine, instead of the recommended sublingual administration, could play an important role in lymphatic obstruction and destruction.. We set up a case-control study in substitution centres, recruiting intravenous drug addicts with and without puffy hands, respectively. The subjects were asked to answer anonymously a questionnaire of 40 items comprising social and demographic status, history of illicit drugs use, buprenorphine misuse and injection practices.. We included 33 cases and 33 controls, mean age of 34 years. They were past heroin users, mainly methadone-substituted. In multivariate analysis, sex (women) (OR = 8.9, P = 0.03), injections in the hands (OR = 5.9, P = 0.03), injections in the feet (OR = 6.5, P = 0.01) and the absence of tourniquet (OR = 7.0, p = 0.02) were significant risk factors for puffy hand syndrome. In 69.7% of the cases and 59.4% of the controls, respectively, there was a high-dose sublingual buprenorphine misuse, although it appeared not to be a significant risk factor for puffy hand syndrome.. Injection practices are likely to cause puffy hands syndrome, but buprenorphine misuse should not be considered as a significant risk factor. However, intravenous drug users must still be warned of local and systemic complications of intravenous drug misuse.

    Topics: Buprenorphine; Case-Control Studies; Female; France; Hand; Humans; Lymphedema; Male; Narcotic Antagonists; Risk Factors; Statistics, Nonparametric; Substance Abuse, Intravenous; Syndrome

2006